IdentificationGeneric Name(2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acidDrugBank Accession NumberDB02588BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-[(1R)-1-{[(2S)-2-Carboxy-2-(4-hydroxyphenyl)acetyl]amino}-1-methoxy-2-oxoethyl]-5-methylene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acid (DB02588)× CloseWeightAverage: 406.3435 Monoisotopic: 406.101230184 Chemical FormulaC18H18N2O9SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUBeta-lactamaseNot AvailableEscherichia coli (strain K12)AbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableClassificationNot classifiedAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyGOYCBKVVHGALFQ-RZAIGCCYSA-NInChIInChI=1S/C18H18N2O9/c1-9-7-29-17(19-13(9)16(26)27)18(8-21,28-2)20-14(23)12(15(24)25)10-3-5-11(22)6-4-10/h3-6,8,12,17,22H,1,7H2,2H3,(H,20,23)(H,24,25)(H,26,27)/t12-,17+,18-/m0/s1IUPAC Name(2R)-2-{1-[(2S)-2-carboxy-2-(4-hydroxyphenyl)acetamido]-1-methoxy-2-oxoethyl}-5-methylidene-5,6-dihydro-2H-1,3-oxazine-4-carboxylic acidSMILESCOC(NC(=O)[C@@H](C(O)=O)C1=CC=C(O)C=C1)(C=O)[C@H]1OCC(=C)C(=N1)C(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound131704211PubChem Substance46506599ChemSpider26328061ZINCZINC000015529397PDBe LigandMOXPDB Entries1fco / 1i5qClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.225 mg/mLALOGPSlogP1.11ALOGPSlogP1.4ChemaxonlogS-3.3ALOGPSpKa (Strongest Acidic)2.9ChemaxonpKa (Strongest Basic)-3.7ChemaxonPhysiological Charge-2ChemaxonHydrogen Acceptor Count10ChemaxonHydrogen Donor Count4ChemaxonPolar Surface Area171.82 Å2ChemaxonRotatable Bond Count8ChemaxonRefractivity94.83 m3·mol-1ChemaxonPolarizability37.01 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.8196Blood Brain Barrier-1.0Caco-2 permeable-0.6744P-glycoprotein substrateSubstrate0.8161P-glycoprotein inhibitor INon-inhibitor0.6713P-glycoprotein inhibitor IINon-inhibitor0.6452Renal organic cation transporterNon-inhibitor0.9366CYP450 2C9 substrateNon-substrate0.8483CYP450 2D6 substrateNon-substrate0.8706CYP450 3A4 substrateSubstrate0.6358CYP450 1A2 substrateNon-inhibitor0.807CYP450 2C9 inhibitorNon-inhibitor0.8242CYP450 2D6 inhibitorNon-inhibitor0.8963CYP450 2C19 inhibitorNon-inhibitor0.7774CYP450 3A4 inhibitorNon-inhibitor0.7485CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7646Ames testNon AMES toxic0.5666CarcinogenicityNon-carcinogens0.9284BiodegradationNot ready biodegradable0.9854Rat acute toxicity2.3783 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9962hERG inhibition (predictor II)Non-inhibitor0.8606  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Beta-lactamaseKindProteinOrganismEscherichia coli (strain K12)Pharmacological actionUnknownGeneral FunctionBeta-lactamase activitySpecific FunctionThis protein is a serine beta-lactamase with a substrate specificity for cephalosporins.Gene NameampCUniprot IDP00811Uniprot NameBeta-lactamaseMolecular Weight41555.3 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at August 01, 2020 13:44 